Your browser doesn't support javascript.
loading
Modulation of the CB1 cannabinoid receptor has potential therapeutic utility in the 3-acetylpyridine cerebellar ataxia rat model.
Ranjbar, Hoda; Soti, Monavareh; Janahmadi, Mahyar; Kohlmeier, Kristi A; Sheibani, Vahid; Ahmadi-Zeidabadi, Meysam; Shabani, Mohammad.
Afiliação
  • Ranjbar H; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, 76198-13159, Iran.
  • Soti M; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, 76198-13159, Iran.
  • Janahmadi M; Department of Physiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Kohlmeier KA; Department of Drug Design and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Sheibani V; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, 76198-13159, Iran.
  • Ahmadi-Zeidabadi M; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, 76198-13159, Iran.
  • Shabani M; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, 76198-13159, Iran. shabani@kmu.ac.ir.
Exp Brain Res ; 240(9): 2339-2348, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35859208

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canabinoides / Ataxia Cerebelar Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Exp Brain Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canabinoides / Ataxia Cerebelar Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Exp Brain Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã País de publicação: Alemanha